Registration is now open for the Fourteenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2026). The meeting is scheduled for September 9–12 at the George R. Brown Convention Center in Houston, Texas. Attendees who register before June 10 2026, will receive early bird registration rates.
SOHO 2026 will be held as a hybrid event to provide flexible participation options including in-person attendance, virtual access, and on-demand viewing. All educational materials will be available as an enduring resource on SOHO365, the SOHO mobile app.
Members of the press seeking a press pass, please contact Leah Sherwood at [email protected]. For questions on SOHO 2026, please contact [email protected].
The annual meeting continues to be a premier event for the exchange of scientific knowledge regarding hematologic malignancies. Attendees can expect a comprehensive program featuring the latest research and treatment strategies from global leaders in the field.
The theme of this year’s meeting,“Advancing care through collaborative science,” reflects a moment when research funding is in flux and cross-sector collaboration is more important than ever. At the heart of next year’s meeting is a related question: How do we sustain the basic science that makes clinical breakthroughs possible?
Plenary session highlights
The SOHO 2026 program features distinguished plenary speakers and prestigious annual awards.
Plenary I TBA: Wednesday, September 9 The Emil J Freireich Distinguished Pioneer Award recognizes SOHO members who have made significant contributions to the mission of the society.
Plenary II: Thursday, September 10, 2026; Susan O’Brien, MD, will receive the Michael J. Keating Outstanding Achievement Award. Dr. O’Brien is a global leader in the treatment of chronic and acute leukemias. Her lecture will focus on her pioneering research in chronic lymphocytic leukemia and the development of targeted therapies, including ibrutinib.
Plenary III: Friday, September 11, 2026; Neal S. Young, MD. Dr. Young is the chief of the Hematology Branch at the National Institutes of Health. He is recognized for his research in bone marrow failure and the development of immunosuppressive treatments for aplastic anemia.
Register today
SOHO invites all investigators and healthcare professionals to join this essential gathering of the hematologic oncology community. Special early registration rates are currently available.
To secure your place for SOHO 2026, visit the official registration page at soho.click/2026. SOHO members receive a 40% discount. Join SOHO for free at http://soho.click/join.
